Evidence map›Paper›PMID 23835328›Full record

Trial reportDiabetes2013

Genetic risk score of 46 type 2 diabetes risk variants associates with changes in plasma glucose and estimates of pancreatic β-cell function over 5 years of follow-up.

Ehm A Andersson, Kristine H Allin, Camilla H Sandholt, Anders Borglykke, Cathrine J Lau, Rasmus Ribel-Madsen, Thomas Sparsø, Johanne M Justesen, Marie N Harder, Marit E Jørgensen and 3 more

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Diabetes, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. A review of standardized metabolic phenotyping of animal models.Mammalian genome : official journal of the International Mammalian Genome Society · 2014
    Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Ehm A AnderssonNovo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics.
Kristine H Allin
Camilla H Sandholt
Anders Borglykke
Cathrine J Lau
Rasmus Ribel-Madsen
Thomas Sparsø
Johanne M Justesen
Marie N Harder
Marit E Jørgensen
Torben Jørgensen
Torben Hansen
Oluf Pedersen
Foundation Center · USNovo Nordisk Foundation Center for Basic Metabolic ResearchGlostrup Hospital · DKNovo Nordisk Foundation · DKAarhus University · DKSteno Diabetes Center · DKUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

More than 40 genetic risk variants for type 2 diabetes have been validated. We aimed to test whether a genetic risk score associates with the incidence of type 2 diabetes and with 5-year changes in glycemic traits and whether the effects were modulated by changes in BMI and lifestyle. The Inter99 study population was genotyped for 46 variants, and a genetic risk score was constructed. During a median follow-up of 11 years, 327 of 5,850 individuals developed diabetes. Physical examinations and oral glucose tolerance tests were performed at baseline and after 5 years (n = 3,727). The risk of incident type 2 diabetes was increased with a hazard ratio of 1.06 (95% CI 1.03-1.08) per risk allele. While the population in general had improved glucose regulation during the 5-year follow-up period, each additional allele in the genetic risk score was associated with a relative increase in fasting, 30-min, and 120-min plasma glucose values and a relative decrease in measures of β-cell function over the 5-year period, whereas indices of insulin sensitivity were unaffected. The effect of the genetic risk score on 5-year changes in fasting plasma glucose was stronger in individuals who increased their BMI. In conclusion, a genetic risk score based on 46 variants associated strongly with incident type 2 diabetes and 5-year changes in plasma glucose and β-cell function. Individuals who gain weight may be more susceptible to the cumulative impact of type 2 diabetes risk variants on fasting plasma glucose.

Indexed as

Polymorphism, Single NucleotideAdultBlood GlucoseBody Mass IndexDenmarkDiabetes Mellitus, Type 2FemaleFollow-Up StudiesGenetic Predisposition to DiseaseGenetic VariationGenome-Wide Association StudyGenotypeGlucose Tolerance TestGlycated HemoglobinHumansIncidenceBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, human

Identifiers

PMID23835328
PMCPMC3781471
OpenAlexW2135984480

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.